The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice

Front Pharmacol
19 June 2019
https://pubmed.ncbi.nlm.nih.gov/31275146/

 

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

 

Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Subscribe to Breast